These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33848066)

  • 1. Editorial Comment: Dietary and circulating vitamin D and risk of renal cell carcinoma: a meta-analysis of observational studies.
    Gregorio BM
    Int Braz J Urol; 2021; 47(4):745-746. PubMed ID: 33848066
    [No Abstract]   [Full Text] [Related]  

  • 2. Dietary and circulating vitamin D and risk of renal cell carcinoma: a meta-analysis of observational studies.
    Wu J; Yang N; Yuan M
    Int Braz J Urol; 2021; 47(4):733-744. PubMed ID: 33146974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin E Intake and Risk of Renal Cell Carcinoma: A Meta-Analysis of 7 Case-Control Studies.
    Shang Y; Yi S; Cui D; Han G; Liu C
    J Ren Nutr; 2015 Jul; 25(4):339-44. PubMed ID: 25455038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of renal tumours in vitamins A and E synthesis workers: a new cause of occupational cancer?
    Richard S; Carrette MN; Béroud C; Ferlicot S; Imbernon E; Iwatsubo Y; Egloff H; Sordet D; Salé JM
    Int J Cancer; 2004 Mar; 108(6):942-4. PubMed ID: 14712501
    [No Abstract]   [Full Text] [Related]  

  • 5. A higher circulating concentration of 25-hydroxyvitamin-D decreases the risk of renal cell carcinoma: a case-control study.
    Li F; Zhao H; Hou L; Ling F; Zhang Y; Tan W
    Int Braz J Urol; 2019; 45(3):523-530. PubMed ID: 30785699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Vitamin D status is associated with serum C-reactive protein and adhesion molecules in patients with renal cell carcinoma.
    Xu S; Song J; Zhang ZH; Fu L; Gao L; Xie DD; Yu DX; Xu DX; Sun GP
    Sci Rep; 2019 Nov; 9(1):16719. PubMed ID: 31723229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of vitamin D receptor gene polymorphism with the risk of renal cell carcinoma: a meta-analysis.
    Ou C; Zhao HL; Zhu B; Huang LS; Li PZ; Lao M
    J Recept Signal Transduct Res; 2014 Dec; 34(6):463-8. PubMed ID: 24840096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Methylenetetrahydrofolate Reductase, Vitamin D Receptor, and Interleukin-16 Gene Polymorphisms With Renal Cell Carcinoma Risk.
    Zhou T; Li H; Xie WJ; Zhong Z; Zhong H; Lin ZJ
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819859413. PubMed ID: 31242814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal cell carcinoma in a child presented as bilateral femur neck fractures caused by severe vitamin D deficiency.
    Aviner S; Dabby D; London D; Feinmesser M; Ash S; Steinberg R; Jakim I
    J Pediatr Hematol Oncol; 2007 Dec; 29(12):848-50. PubMed ID: 18090936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial comment.
    McDougal WS
    J Urol; 2009 Oct; 182(4):1293; discussion 1293. PubMed ID: 19683301
    [No Abstract]   [Full Text] [Related]  

  • 11. Meta-analysis of vitamin D, calcium and the prevention of breast cancer.
    Chen P; Hu P; Xie D; Qin Y; Wang F; Wang H
    Breast Cancer Res Treat; 2010 Jun; 121(2):469-77. PubMed ID: 19851861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial comment.
    Krishnamurthi V
    Urology; 2013 Apr; 81(4):914. PubMed ID: 23414688
    [No Abstract]   [Full Text] [Related]  

  • 13. No association between dietary acrylamide and renal cell carcinoma: an updated meta-analysis.
    Jiang F; Teng M; Zhu YX; Li YJ
    J Sci Food Agric; 2020 May; 100(7):3071-3077. PubMed ID: 32077494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Importance of Vitamins A, E and Retinol-binding Protein 4 in Renal Cell Carcinoma Patients.
    Sobotka R; Čapoun O; Kalousová M; Hanuš T; Zima T; Koštířová M; Soukup V
    Anticancer Res; 2017 Jul; 37(7):3801-3806. PubMed ID: 28668878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D status may explain racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era.
    Grant WB
    Cancer; 2016 Dec; 122(24):3892-3893. PubMed ID: 27627191
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to vitamin D status may explain racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era.
    Rose TL; Milowsky MI
    Cancer; 2016 Dec; 122(24):3893. PubMed ID: 27627047
    [No Abstract]   [Full Text] [Related]  

  • 17. Comment on 'The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis'.
    Braillon A
    Br J Cancer; 2017 Jul; 117(2):e3. PubMed ID: 28641318
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel targeting modality for renal cell carcinoma: human osteocalcin promoter-mediated gene therapy synergistically induced by vitamin C and vitamin D₃.
    Johnson NA; Chen BH; Sung SY; Liao CH; Hsiao WC; W K Chung L; Hsieh CL
    J Gene Med; 2010 Nov; 12(11):892-903. PubMed ID: 21105150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary Intake of Vitamins in Different Options of Treatment in Chronic Kidney Disease: Is There a Deficiency?
    Jankowska M; Szupryczyńska N; Dębska-Ślizień A; Borek P; Kaczkan M; Rutkowski B; Małgorzewicz S
    Transplant Proc; 2016 Jun; 48(5):1427-30. PubMed ID: 27496421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reply to 'Comment on 'The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis''.
    Zgaga L; Vaughan-Shaw PG; O'Sullivan F; Farrington SM; Theodoratou E; Campbell H; Dunlop MG
    Br J Cancer; 2017 Jul; 117(2):e4. PubMed ID: 28641317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.